Patent directory · USPTO A61K / A61P
Patents matching “Arrowhead Research Corporation”
16 pharma patents match "Arrowhead Research Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 16 pharmaceutical patents matching "Arrowhead Research Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9371529
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
granted -
US 9347062
Interfering RNA delivery system and uses thereof
granted -
US 9289514
Low density lipoprotein receptor-mediated siRNA delivery
granted -
US 9233170
Interfering RNA delivery system and uses thereof
granted -
US 9206428
RNAi-mediated inhibition of histamine receptor H1-related conditions
granted -
US 9173896
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
granted -
US 9150862
siRNA targeting VEGFA and methods for treatment in vivo
granted -
US 9139833
Modified small interfering RNA molecules and methods of use
granted -
US 9139834
RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis
granted -
US 9133462
dsRNA for treating viral infection
granted -
US 9114152
Transferrin/transferrin receptor-mediated siRNA delivery
granted -
US 9096637
Organic compositions to treat HSF1-related diseases
granted -
US 9084808
Modified small interfering RNA molecules and methods of use
granted -
US 9080175
Organic compositions to treat Beta-ENaC-related diseases
granted -
US 9074212
RNAi inhibition of alpha-ENaC expression
granted -
US 8946176
Compositions and methods for inhibiting expression of RRM2 genes
granted